Describing universal Strongyloides serologic screening among pediatric intestinal and liver transplant recipients.

While institutions continue to analyze the cost-benefit of universal testing vs. universal prophylaxis vs. targeted screening, the decision must encompass the patient population, rolling cumulative incidence, and morbidity and mortality related to this disease.